Clinical trial
Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump…
NCT00428207 · Joslin Diabetes Center, Other · Terminated
Key facts
| NCT number | NCT00428207 |
|---|---|
| Title | Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy |
| Official title | Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy |
| Lead sponsor | Joslin Diabetes Center, Other |
| Collaborators | Novo Nordisk A/S Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Insulin Aspart versus Insulin Lispro, Insulin Lispro versus Insulin Aspart |
| Enrollment | 4 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jan 29, 2007 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: